SYDNEY, June 28 (Bernama-GLOBE NEWSWIRE) — George Clinical and EPS Corporation (EPS), a global CRO based in Japan are collaborating on a rare Japanese academia-led global study seeking to advance treatments for unmet needs in Asian populations.
In 2019 George Clinical and EPS formed a strategic partnership to help expand their operations across the Asia-Pacific region. Together the organizations have partnered on over 20 studies, mainly in oncology, kidney, metabolic and cardiovascular diseases therapeutic areas. In this reciprocal strategic partnership, both companies come together to provide a seamless operating capability for clinical trials across the Asia-Pacific region and globally.